Researchers examined the generational differences across the population of the UK in risk perceptions, emotions, and beliefs about climate change and climate engagement.
‘Very Clear Signal’ That Survival Improved With Addition of Durvalumab in SCLC
The phase III ADRIATIC trial showed that adding consolidation treatment with durvalumab (Imfinzi) after concurrent chemoradiotherapy significantly improved progression-free and overall survival in patients with
July 9, 2024